These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 13496268)

  • 1. [Resistance of Mycobacterium tuberculosis to antituberculotics in synthetic culture media].
    BANYASZ T
    Tuberkulozis; 1957; 10(5-6):107-9. PubMed ID: 13496268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid].
    JANKOV M
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1955; 7(1-4):228-34. PubMed ID: 13405406
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the drug resistance in Mycobacterium tuberculosis var. hominis.
    MIURA K; NODA Y; TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):182-5. PubMed ID: 13385195
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid.
    TSUKAMURA M
    J Antibiot (Tokyo); 1956 Sep; 9(5):186-90. PubMed ID: 13385196
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance determination in practice in a tuberculosis clinic].
    ERMISCH K; ERMISCH U
    Zentralbl Bakteriol Orig; 1955 Dec; 164(8):566-76. PubMed ID: 13371902
    [No Abstract]   [Full Text] [Related]  

  • 6. RESISTANT tubercle bacilli.
    Lancet; 1957 Apr; 272(6973):825-6. PubMed ID: 13417612
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 8. [New laboratory accomplishments in thoracic pathology].
    CETRANGOLO A
    Rev Med Cubana; 1956 May; 67(5):418-25. PubMed ID: 13371028
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of resistance by Mycobacterium tuberculosis to streptomycin, viomycin, and paraaminosalicylic acid.
    JOSIUKAS A; ROY TE; BOYD G
    AMA Am J Dis Child; 1952 Dec; 84(6):747-8. PubMed ID: 12996007
    [No Abstract]   [Full Text] [Related]  

  • 10. A quantitative analysis of the resistance of Mycobacterium tuberculosis to streptomycin, isoniazid and PAS.
    TSUKAMURA M; NODA Y; MIURA K
    Kekkaku; 1956 Feb; 31(2):107-10. PubMed ID: 13320628
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensitivity to antituberculous drugs of bacillary strains from initial tuberculosis in children].
    DEBRE R; FOUSSEREAU S; NOUFFLARD H
    Presse Med (1893); 1956 Oct; 64(78):1791-3. PubMed ID: 13389308
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test.
    DUNBAR FP; DAVIS R; JEFFERIES MB
    Am Rev Tuberc; 1958 Feb; 77(2):350-5. PubMed ID: 13509034
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of 58 titrations of sensitivity to streptomycin, PAS and isoniazid of Mycobacterium tuberculosis].
    BURDIN JC; SCHMITT J; de LAVERGNE ; BRIQUEL P; RIBAR D
    Rev Med Nancy; 1960 Feb; 85():131-5. PubMed ID: 13806020
    [No Abstract]   [Full Text] [Related]  

  • 14. The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis.
    SINGH B; MITCHISON DA
    J Gen Microbiol; 1955 Aug; 13(1):176-84. PubMed ID: 13252227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical observations on the problem of resistance of tubercle bacteria].
    PICKROTH G; BUSCHMANN E
    Z Gesamte Inn Med; 1954 Mar; 9(6):285-90. PubMed ID: 13170251
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods for determining the sensitivity of Mycobacterium tuberculosis to isoniazid, streptomycin and PAS.
    WORSSAM AR; COLLARD P; CARROLL JD; KNOX R
    Tubercle; 1956 Apr; 37(2):73-80. PubMed ID: 13324954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fundamental experiments on combined effects of three anti-tuberculous agents, streptomycin, PAS and isoniazid. I. Studies mainly on the course of the resistance development of M. tuberculosis serially transferred in the cultural environment of three drugs used concomitantly].
    MIYAMOTO Y; UENO K
    Kekkaku; 1955 Nov; 30(11):659-63. PubMed ID: 13286850
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance of the tubercle-bacillus to drugs in general and PAS in particular].
    DE BEULE R
    Schweiz Z Tuberk; 1952; 9(2):76-85. PubMed ID: 14958380
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of action of para-aminosalicylic acid in preventing the emergence of resistance to streptomycin in mycobacterium tuberculosis.
    TSUKAMURA M
    J Antibiot (Tokyo); 1955 Dec; 8(6):196-200. PubMed ID: 13319223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.